Loading...

PRPH PROPHASE LABS INC Capital Structure Changes 8-K Filing

PRPH

PRPH

PROPHASE LABS INC

(PRPH)

2025 8-K

Stock Split Announcement

Stock Split Action

Stockholder Meeting Results

Legal Unsealing Notice

Financial Results Update

Sales Agreement Signed

Strategic Advisory Agreement

Stockholder Approvals

Agreement Termination

Proxy Statement Update

Financial Results Release

Equity Offerings

Debt-Equity Swaps

Debt-Equity Swaps

Non-Compliance with Listing...

Financial Statements

Earnings Report

Earnings Update

Earnings Report

Earnings Report

Earnings Report

Earnings Report

Earnings Update

Earnings Report

Earnings Update

Earnings Report

Earnings Report

Earnings Report

Financial Results

Financial Results for Q3 2021

Quarterly Earnings Reports

Filing with Quantitative Data

Financial Performance

Financial Results

Quantitative Data

Financial Results for Q1 2021

Filing with Quantitative Data

Financial Results

Financial Results

Quarterly Earnings Reports

Quantitative Data

Quarterly Earnings Reports

External Links:

On July 22, 2025, ProPhase Labs, Inc. signed a deal for a $3 million financing involving senior secured convertible notes and warrants, aimed at raising capital for working expenses. The company must obtain stockholder approval by November 22, 2025, to issue shares exceeding 19.99% of its common stock.

AI Assistant

PROPHASE LABS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.